Journal of pharmacy practice
-
Randomized Controlled Trial
Comparison of Monoclonal Antibodies for Treatment of Uncontrolled Eosinophilic Asthma.
To summarize the current literature for Food and Drug Administration (FDA)-approved monoclonal antibodies used as add-on maintenance therapy in uncontrolled eosinophilic asthma. ⋯ Five monoclonal antibodies are available for uncontrolled eosinophilic asthma. Choice depends on patient factors. Future studies should focus on cost-effectiveness of treatment, drug-drug comparisons, and long-term efficacy and safety.